Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
quercetin-3'-o-phosphate
- Development stage
- Phase 2
- Modality
- Small Molecules
01
Overview
Quercetin-3'-O-phosphate is a synthetic phosphorylated derivative of the flavonol quercetin. It is classified as a small molecule and has been investigated for its potential to treat metabolic disorders, specifically insulin resistance and impaired glucose tolerance. Mechanistically, it acts as an antagonist of adenosine A receptors, which may contribute to its effects on glucose metabolism and other metabolic pathways. As a member of the flavonol class, it also likely retains antioxidant properties typical of this group[1][2][3].
- Other names
- quercetin-3'-o-phosphate3'-quercetin phosphateQuercetin 3'-phosphateUNII-E2I4458LJNUNII-E-2I4458LJNUNII-E 2I4458LJN1111616-69-3
02
Targets
ADOR (Adenosine receptors)
Beyond the preview
Go deeper on quercetin-3'-o-phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on quercetin-3'-o-phosphate.